Methylphenidate Hydrochloride Cd Capsule, Extended Release
Product Images NDC 0527-4584

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride Cd (NDC 0527-4584). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylphenidate HCl Er Capsules Cd 1)

Chemical structure diagram of methylphenidate hydrochloride, showing its molecular framework including a phenyl ring, ester group, piperidine ring, and hydrochloride salt moiety.*

FDA Label Image

60 mg Label (Methylphenidate HCl Er Capsules Cd 10)

Label of methylphenidate hydrochloride CD extended-release capsules, 60 mg strength. The label includes storage instructions, dosage warnings, and directs the use of an accompanying Medication Guide. It indicates the product is distributed by Lannett Company, Inc., Philadelphia, PA, and contains 100 capsules per container.*

FDA Label Image

Figure 1 (Methylphenidate HCl Er Capsules Cd 2)

A line graph showing mean plasma concentration (Cp) of methylphenidate over time after dosing, measured in ng/mL on the y-axis and time in hours on the x-axis. It compares three dosing regimens: 10 mg immediate-release at 0 and 4 hours, 20 mg methylphenidate HCl extended-release capsules once, and two 20 mg extended-release capsules. The graph illustrates the pharmacokinetic profiles of these dosing schedules up to 9 hours post-dose.*

FDA Label Image

Figure 2 (Methylphenidate HCl Er Capsules Cd 3)

A bar chart comparing least squares mean change from baseline for methylphenidate hydrochloride extended-release capsules CD and placebo. The y-axis displays the change from baseline, showing a larger negative change for methylphenidate HCl than for placebo. Each bar includes error bars representing variability, with sample sizes noted (155 for methylphenidate and 159 for placebo).*

FDA Label Image

Figure 3 (Methylphenidate HCl Er Capsules Cd 4)

A bar graph comparing the LS mean change from baseline between methylphenidate hydrochloride extended-release capsules CD and placebo, shown separately for AM and PM times. The y-axis measures change from baseline, with methylphenidate groups showing larger negative changes than placebo at both times. Sample sizes are 155 and 159 for methylphenidate and placebo, respectively.*

FDA Label Image

10 mg Label (Methylphenidate HCl Er Capsules Cd 5)

Label for methylphenidate hydrochloride CD 10 mg extended-release capsules, once daily oral dosage form. The label indicates 100 capsules per container and includes storage instructions, dosage warnings, and distributor information for Lannett Company, Inc.*

FDA Label Image

20 mg Label (Methylphenidate HCl Er Capsules Cd 6)

Label for Methylphenidate HCl Extended-Release Capsules CD, 20 mg strength, in a capsule oral dosage form. The label indicates it is a once daily prescription medication provided by Lannett Company, Inc. It includes storage instructions at 25°C with permitted excursions and a barcode. The package contains 100 capsules.*

FDA Label Image

30 mg Label (Methylphenidate HCl Er Capsules Cd 7)

Label for Methylphenidate HCl Extended-Release Capsules CD 30 mg, an oral prescription drug by Lannett Company, Inc. The label includes dosage and storage instructions, a medication guide notice, and indicates the package contains 100 capsules.*

FDA Label Image

40 mg Label (Methylphenidate HCl Er Capsules Cd 8)

Label for methylphenidate hydrochloride CD extended-release capsules, 40 mg strength. The label indicates it is for oral use, distributed by Lannett Company, Inc., with a package count of 100 capsules. It includes directions not to chew or crush the capsules and mentions storage conditions and the requirement of a Medication Guide with each prescription.*

FDA Label Image

50 mg Label (Methylphenidate HCl Er Capsules Cd 9)

Label for methylphenidate hydrochloride CD 50 mg extended-release capsules, oral use. The label indicates it is distributed by Lannett Company, Inc. and contains 100 capsules. Storage instructions are provided, along with a reminder that a Medication Guide is required for every prescription dispensed. The NDC number 0527-4583-37 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.